AMY SECOR: Open Payments
NPI 1629082425 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 34 payments from 11 companies in 2025. Trend: 2023 $709 · 2024 $709 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $167 |
| Phathom Pharmaceuticals, Inc. | 7 | $73 |
| Gilead Sciences, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Janssen Biotech, Inc. | 2 | $45 |
| Ardelyx, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| Braintree Laboratories, Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
Products named: RINVOQ, VOQUEZNA, TREMFYA, ENTYVIO, IBSRELA, OMVOH, MAVYRET, SUTAB.
Industry payments across NY — which companies pay providers there.
